Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.
about
Management of locally advanced and metastatic colon cancer in elderly patientsNeutralization of IL-8 prevents the induction of dermatologic adverse events associated with the inhibition of epidermal growth factor receptorPreservation of organ function in head and neck cancer.Acneiform rash due to epidermal growth factor receptor inhibitors: high-level laser therapy as an innovative approach.Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert Consultation Process.Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.Targeted therapies in colorectal cancer-an integrative view by PPPMObservational study on quality of life, safety, and effectiveness of first-line cetuximab plus chemotherapy in KRAS wild-type metastatic colorectal cancer patients: the ObservEr Study.Treatment of children with high grade glioma with nimotuzumab: a 5-year institutional experienceThe role of cetuximab in the management of head and neck cancers.Cetuximab in non-melanoma skin cancer.The predictive role of skin rash with cetuximab and panitumumab in colorectal cancer patients: a systematic review and meta-analysis of published trials.Update of cetuximab for non-melanoma skin cancer.Targeting the epidermal growth factor receptor in solid tumors: focus on safety.Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors.Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck."I Lost My Image, the Image Others Know Me By": Findings From a Hermeneutic Phenomenological Study of Patients Living With Treatment-Induced Cutaneous Toxicities.Unplanned presentations of cancer outpatients: a retrospective cohort study.Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.Dasatinib-induced Seborrheic Dermatitis-like Eruption.Skin rash during cetuximab treatment in advanced colorectal cancer: is age a clinical predictor?A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors.Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer.Body image concerns after colorectal cancer surgery.Adverse skin reactions during treatment with cetuximab plus radiotherapy: Multidisciplinary approach to minimize radio-chemotherapy interruption.
P2860
Q27026129-51D54458-AF65-4E9D-A707-2486FB486E6FQ28728031-867B24C3-B07C-4F8E-B724-711DA5149416Q30459136-03F475DF-8CB4-4C1C-9DFC-02216544FF3EQ34084382-7C1C7F7D-BE92-467E-9F61-404E759C936FQ35069314-2E106E53-1C43-43C2-A70E-52FCD79CACBEQ36026706-464D1DE0-A352-4769-B147-D4C41EAAB7AAQ36646911-7948BBCA-A775-4B63-9B68-11DD99EBF875Q37429996-F7B73D28-340D-41A7-93D9-429176E56EB6Q37484213-5930FF13-3CD1-452E-8665-3B5D0D4655FFQ37993120-BB4438E1-582B-4F98-B778-CF76E1E07E9AQ38004033-2CB800E1-FDC7-4E7B-9A18-2ADF7F3BE9DCQ38074290-50906C86-4383-4C2E-86B8-2F3B1C41A28EQ38175499-9FDA21AE-B41E-490E-9664-318FD3A90EC0Q38200654-FFBB5E72-097D-4336-A873-40FF7F71B4E1Q38207484-91D52B75-1D1F-4A1E-96C1-052A10B3A8E2Q38936131-F0BC4653-4256-4852-A47F-01BCA15A2ED0Q39849391-DFA70391-BF4A-47EC-83B9-2264309C2BA4Q40282702-6071A1C0-3C28-48D9-BA8B-9185C31CAD35Q41696585-1EE69FC2-8F32-46A1-8C2C-5EC821B09CF9Q43202567-AB9E3924-36F7-40FE-BC4E-F146D54C5D6CQ43427689-240A7D9F-AB43-4C74-BEAA-8E8C12E2A04DQ43439165-45220A58-2E48-40CD-8326-A01F3C8BBB39Q44567674-75F30587-1C0C-4118-AC6F-D719042494C6Q53489414-2F5942A3-2833-47AA-93FD-241BA8442223Q54350777-DD859127-D11B-4946-926C-A5D4F1CA5046
P2860
Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@ast
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@en
type
label
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@ast
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@en
prefLabel
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@ast
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@en
P2093
P2860
P921
P1433
P1476
Management of skin toxicity as ...... chemotherapy or radiotherapy.
@en
P2093
Carlo Antonio Barone
Carmine Pinto
Daris Ferrari
Elvio Grazioso Russi
European Society of Medical Oncology
Giampiero Girolomoni
Marco Carlo Merlano
P2860
P304
P356
10.1634/THEONCOLOGIST.2010-0298
P577
2011-01-27T00:00:00Z